Simmons advised Ascendis Pharma on partnership with Teijin in Japan, while Japanese firm TMI Associates advised on Japanese law matters. Biopharmaceutical company Ascendis Pharma has established...
Ascendis Pharma’s Strategic Partnership with Teijin Limited
Ascendis Pharma’s $150 Million Royalty Funding Agreement with Royalty Pharma
Latham & Watkins and Mazanti-Andersen acted as legal advisors to Ascendis on the transaction, while Goodwin Procter, Kromann Reumert and Fenwick & West acted as legal...
Ascendis Pharma’s $400 Million ADSs Public Offering
Latham & Watkins and Mazanti-Andersen represented Ascendis Pharma A/S in the transaction. Ascendis Pharma A/S (Nasdaq: ASND) has announced the pricing of its underwritten public offering of...